FDA accepts Biological License Application for reslizumab
A Guide to the PRESCRIPTION AND SERVICE REQUEST FORM FOR CINQAIR® ( reslizumab) Injection
CINQAIR® (reslizumab) Injection – About Asthma Control
Teva files MAA for asthma treatment reslizumab
Cinqair (reslizumab): Basics, Side Effects & Reviews
Cinqair (Reslizumab) 100mg/10mL Injection – Apothera
Teva's Asthma Therapy Reslizumab Fails in Late-Stage Studies
Teva-Handok wins approval for anti-asthma injection < Pharma < Article - KBR
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
Older Patients with Asthma Do Well with Reslizumab | RT
Reslizumab: FDA panel recommends approval for adults, but not children | CHEST Physician
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Teva Reports Two Successful Phase III Studies For Reslizumab In Asthma
Teva Announces EMA Validation of Reslizumab Marketing Authorization Application
Reslizumab | New Drug Approvals
Attachment: Product Information: Reslizumab
Israeli Pharma gets FDA Approval for Asthma Antibody
Teva filled Biologics License Application for reslizumab Archives • NCK Pharma
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
Reslizumab Reslizumab (Teva) | Bioz | Ratings For Life-Science Research
Teva Announces Biologics License Application FDA Acceptance of Reslizumab For Asthma
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma
NICE Recommends CINQAERO (reslizumab) for the Treatment of Severe Eosinophilic Asthma » FINCHANNEL
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
